Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: StockMiser who wrote (649)	5/7/1999 4:38:00 PM
From: Garry K.	of 2344

The recent annual report from Biomira IMHO has a distinct tone that differs from other years, particularly from Dr. Macpherson's commentary. I sence a tremendous amount of confidence in the pipeline of developments, especially the Theratope trial. I have always felt that Biomira has gone about their work in the most professional, discreet manner. It is encouraging to see that the company itself is getting excited about Theratope, as we may be on the verge of graduating from a little Canadian biotech company, to a major player in the arena of cancer vaccines. Biomira has never touted its own horn, or hyped its developments to the investment community. But perhaps we are seeing a hint that the company is confident in Theratope's chances. As a cancer patient quoted in the report said, the company "deserves it!" Looking forward to next week. Good luck! Garry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next